BTIG MedTech conference in Utah on 13-14 February.13 Feb 2024 09:45
Last week. the Centers for Medicare and Medicaid Services has published a draft local coverage determination for Renalytix for KidneyIntelX and kidneyintelIX.dkd. The Medicare price is $950/test. The specified coverage is for patients with diagnosed Tupe 2 diabetes and Stage 1-3b Chronic Kidney Disease.
Renalytix is participating in the BTIG MedTech conference in Utah on 13-14 February.
Kidney disease affects more than 850 million people around the world and 38 million people in the US have chronic kidney disease. Around 35 million US people have Type 2 diabetes.
A study of KidneyIntelX at a major US clinical centre. After one year, blood pressure control improved as did blood glucose control. The rate of kidney function decline reduced across all risk categories.